Check Point director gets 5,000 options, RSUs

CHKP granted director Tzipi Ozer-Armon new RSUs and stock options vesting through 2027, increasing her direct equity-based holdings.

Rhea-AI Filing Summary

CHECK POINT SOFTWARE TECHNOLOGIES LTD (CHKP) reported that director Tzipi Ozer-Armon received new equity awards. On September 2, 2026, the director was granted 5,000 stock options with an exercise price of $133.89 per share, expiring September 1, 2033, and 1,120 Restricted Share Units (RSUs) with no cash purchase price.

The 5,000 options are scheduled to vest in tranches of 2,500 on March 2, 2027, 1,250 on June 2, 2027, and 1,250 on September 2, 2027, subject to continued service. The 1,120 RSUs are scheduled to vest 560 on March 2, 2027, 280 on June 2, 2027, and 280 on September 2, 2027, also subject to continued service. Following the RSU grant, the director directly holds 5,490 Ordinary Shares, including 1,516 RSUs scheduled to vest through September 2, 2027. Footnotes also state the director holds options over an additional 40,000 Ordinary Shares, of which 33,750 were vested as of September 3, 2026 and 6,250 are scheduled to vest on January 1, 2027. No Rule 10b5-1 trading plan is reported for these awards.

Insider Trade Summary

Grant/Award: 6,120 shares

Grant/Award 2 txns

Insider Ozer-Armon Tzipi

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options F3, F4	5,000	$133.89	$669K
Grant/Award	Ordinary Shares, NIS 0.01 Per Share F1, F2	1,120	$0.00	$0.00

Holdings After Transaction: Stock Options — 5,000 contracts (Direct); Ordinary Shares, NIS 0.01 Per Share — 5,490 shares (Direct)

Footnotes (4)

1. F1. The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs) that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
2. F2. Includes 1,516 RSUs that are scheduled to vest as follows: 396 on January 1, 2027, 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
3. F3. The Reporting Person was granted by the Issuer options to purchase 5,000 Ordinary Shares that are scheduled to vest as follows: 2,500 on March 2, 2027, 1,250 on June 2, 2027, 1,250 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date.
4. F4. In addition, there are 40,000 Ordinary Shares underlying options held by the Reporting Person, of which 33,750 are vested as of September 3, 2026, and the remaining 6,250 Ordinary Shares underlying the option will vest on January 1, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on the vesting date.

Key Figures

Stock options granted: 5,000 options Option exercise price: $133.89 per share Option expiration date: September 1, 2033 +5 more

8 metrics

Stock options granted 5,000 options Options to purchase Ordinary Shares granted on September 2, 2026

Option exercise price $133.89 per share Exercise price for 5,000 stock options granted on September 2, 2026

Option expiration date September 1, 2033 Expiration date for 5,000 stock options

RSUs granted 1,120 RSUs Restricted Share Units granted on September 2, 2026

Direct Ordinary Shares and RSUs after grant 5,490 shares Total direct Ordinary Shares including RSUs following RSU acquisition

RSUs scheduled to vest 1,516 RSUs RSUs vesting between January 1, 2027 and September 2, 2027

Additional options held 40,000 options Options over Ordinary Shares held, 33,750 vested as of September 3, 2026

Remaining options to vest 6,250 options Options scheduled to vest on January 1, 2027

Key Terms

Restricted Share Units (RSUs), Ordinary Shares, exercise price, vesting date, +1 more

5 terms

Restricted Share Units (RSUs) financial

"The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs)"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

Ordinary Shares financial

"Each RSU represents the right to receive one Ordinary Share of the Issuer"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"options to purchase 5,000 Ordinary Shares with an exercise price of $133.89"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting date financial

"subject to the Reporting Person's continued service ... on each vesting date"

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these awards"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What equity awards did CHKP grant to director Tzipi Ozer-Armon on September 2, 2026?

CHKP granted Tzipi Ozer-Armon 5,000 stock options at an exercise price of $133.89 per share, expiring September 1, 2033, and 1,120 RSUs with no cash purchase price, all subject to continued service through stated vesting dates.

What is the vesting schedule for the new RSUs reported in CHKP’s Form 4?

The 1,120 RSUs vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, and 280 on September 2, 2027, subject to Tzipi Ozer-Armon’s continued service as a Service Provider on each vesting date.

How do the new CHKP stock options granted to Tzipi Ozer-Armon vest?

The 5,000 stock options vest in three tranches: 2,500 on March 2, 2027, 1,250 on June 2, 2027, and 1,250 on September 2, 2027, provided she continues serving as a Service Provider on each vesting date.

What are Tzipi Ozer-Armon’s direct Ordinary Share and RSU holdings in CHKP after this filing?

After the RSU grant, she directly holds 5,490 Ordinary Shares, which includes 1,516 RSUs scheduled to vest 396 on January 1, 2027, 560 on March 2, 2027, 280 on June 2, 2027, and 280 on September 2, 2027, subject to continued service.

What additional CHKP stock options does Tzipi Ozer-Armon hold beyond the new grant?

In addition to the new 5,000-option grant, she holds options over 40,000 Ordinary Shares; 33,750 were vested as of September 3, 2026, and the remaining 6,250 are scheduled to vest on January 1, 2027, subject to continued service.

Were Tzipi Ozer-Armon’s CHKP equity awards made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates no Rule 10b5-1 plan is reported; the document-level checkbox for Rule 10b5-1 arrangements is marked false, and the footnotes do not describe any such trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:31 PM Accepted by SEC EDGAR 09/03/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ozer-Armon Tzipi

(Last) (First) (Middle)

5 SHLOMO KAPLAN STREET

(Street)

TEL AVIV 6789159

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHECK POINT SOFTWARE TECHNOLOGIES LTD [ CHKP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares, NIS 0.01 Per Share	09/02/2026		A(1)		1,120	A	$0.00	5,490(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$133.89	09/02/2026		A		5,000		(3)	09/01/2033	Ordinary Shares	5,000	$133.89	5,000(4)	D

Explanation of Responses:

1. The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs) that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.

2. Includes 1,516 RSUs that are scheduled to vest as follows: 396 on January 1, 2027, 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.

3. The Reporting Person was granted by the Issuer options to purchase 5,000 Ordinary Shares that are scheduled to vest as follows: 2,500 on March 2, 2027, 1,250 on June 2, 2027, 1,250 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date.

4. In addition, there are 40,000 Ordinary Shares underlying options held by the Reporting Person, of which 33,750 are vested as of September 3, 2026, and the remaining 6,250 Ordinary Shares underlying the option will vest on January 1, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on the vesting date.

	/S/ Shira Yashar - Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)